NeuroBlate is a minimally invasive procedure. Minimally invasive procedures are generally well tolerated, have a short recovery time and patients go home with 1-2 stitches.
The NeuroBlate System is intended for ablating intracranial soft tissue, including brain structures. There are no known or reported contraindications. The technology is not appropriate for every lesion type and location. It may be difficult to use the technology on certain large or irregularly shaped lesions. Patients must be able to undergo MRI exposure.
Possible adverse events include, but are not limited to, compromised device function, hematoma, embolic events, edema, bleeding, unintended major tissue damage and permanent neurological deficits. Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events.